MedTrace Logo

Measurement Algorithm Control, Optimization, and Performance Evaluation of the Vital USA GlucoseDetect

NCT04340648 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2020-04-09

No results posted yet for this study

Summary

Measurement Algorithm Control and Optimization with Subsequent Performance Evaluation of the Vital USA GlucoseDetect™ During a Standardized Meal Test in Patients with Diabetes mellitus Type 1 and Type 2

Conditions

Interventions

DEVICE

Vital GlucoseDetect

11 time points for blood glucose measurements over 210 min including the ingestion of a standardized meal 30 min after the first blood glucose measurement.

Sponsors & Collaborators

  • Sciema UG

    lead OTHER

Principal Investigators

  • Andreas Pfützner, Prof. Dr. Dr. · Pfützner Science & Health Institute GmbH

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-03
Primary Completion
2019-10-31
Completion
2019-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04340648 on ClinicalTrials.gov